Farmacia Hospitalaria y Farmacogenómica

Villanueva-Bueno, C; Collado-Borrell, R; Revuelta-Herrero, JL; Fernandez-Roman, AB; Casado-Abad, G; Escudero-Vilaplana, V.

Implementation of a methodology to assess patient reported outcomes in lung cancer patients: The PeOpLe (Patient-reported Outcomes in Lung cancer) study protocol

FARMACIA HOSPITALARIA. 2022; 46(4): 265-269 Nº de citas: 1 [doi:10.7399/fh.11835]

Moreno-Martinez, E; de la Serna-Torroba, J; Escudero-Vilaplana, V; Hernandez-Rivas, JA; Sanchez-Cuervos, M; Sanchez-Hernandez, R.

Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain

FARMACIA HOSPITALARIA. 2022; 46(3): 121-132 [doi:10.7399/fh.11829]

Collado-Borrell, R; Escudero-Vilaplana, V; Narrillos-Moraza, A; Villanueva-Bueno, C; Herranz-Alonso, A; Sanjurjo-Saez, M.

Patient-reported outcomes and mobile applications. A review of their impact on patients' health outcomes

FARMACIA HOSPITALARIA. 2022; 46(3): 173-181 Nº de citas: 20 [doi:10.7399/fh.11830]

Garcia-Sanchez, S; Somoza-Fernadez, B; de Lorenzo-Pinto, A; Ortega-Navarro, C; Herranz-Alonso, A; Sanjurjo, M.

Mobile Health Apps Providing Information on Drugs for Adult Emergency Care: Systematic Search on App Stores and Content Analysis

JMIR mHealth and uHealth. 2022; 10(4): Nº de citas: 9 [doi:10.2196/29985]

Martinez-Barrio, J; Lopez, JAM; Galindo, M; Ais, A; Sanchez, NM; Cano, L.

Importance of family planning in patients with immune-mediated inflammatory diseases: A multidisciplinary approach

Reumatologia Clinica. 2022; 18(4): 200-206 [doi:10.1016/j.reuma.2020.11.007]

Hoyo-Munoz, A; Collado-Borrell, R; Escudero-Vilaplana, V; Bastos-Oreiro, M; Herranz-Alonso, A; Sanjurjo-Saez, M.

Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2022; 47(4): 548-551 Nº de citas: 5 [doi:10.1111/jcpt.13513]

Diaz-Navarro, M; Hafian, R; Manzano, I; Perez-Granda, MJ; Cercenado, E; Pascual, C; Rodriguez, C; Munoz, P; Guembe, M.

A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing

Infectious Diseases and Therapy. 2022; 11(2): 743-755 Nº de citas: 7 [doi:10.1007/s40121-021-00579-4]

Amor-Garcia, MA; Rodriguez-Gonzalez, CG; Chamorro-de-Vega, E; Herranz-Alonso, A; Sanjurjo-Saez, M.

Dolutegravir-Based Dual Therapies in HIV Pretreated Patients: A Real-Life Study in Madrid

ANNALS OF PHARMACOTHERAPY. 2022; 56(4): 401-411 Nº de citas: 7 [doi:10.1177/10600280211038504]

Butragueno-Laiseca, L; Martin, GM; Cortes, RG; Galan, CR; de Marigorta, ZMDM; Anton, JG; Nunez, AR; Fernandez-Llamazares, CM; Manrique-Rodriguez, S; Cid, JLH.

Multicenter randomized clinical trial comparing dexamethasone versus placebo in preventing upper airway obstruction after extubation in critically ill children

Scientific Reports. 2022; 12(1): Nº de citas: 11 [doi:10.1038/s41598-022-08178-0]

Romero-Jimenez, R; Escudero-Vilaplana, V; Chamorro-de-Vega, E; Ais-Larisgoitia, A; Matilla, MEL; Herranz-Alonso, A; Sanjurjo, M.

The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search

JOURNAL OF MEDICAL INTERNET RESEARCH. 2022; 24(3): Nº de citas: 7 [doi:10.2196/31016]

Tejerina, F; Catalan, P; Rodriguez-Grande, C; Adan, J; Rodriguez-Gonzalez, C; Munoz, P; Aldamiz, T; Diez, C; Perez, L; Fanciulli, C; de Viedma, DG; Gregorio Maranon Microbiol ID COVI.

Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19

BMC INFECTIOUS DISEASES. 2022; 22(1): Nº de citas: 100 [doi:10.1186/s12879-022-07153-4]

Garcia-Moreno, FJ; Escobar-Castellanos, M; Maranon, R; Rivas-Garcia, A; Manrique-Rodriguez, S; Mora-Capin, A; Fernandez-Llamazares, CM.

Adecuacy of pediatric antimicrobial prescribing in the Emergency Department at discharge

ANALES DE PEDIATRIA. 2022; 96(3): 179-189 Nº de citas: 7 [doi:10.1016/j.anpedi.2020.11.019]

García-Moreno FJ; Escobar-Castellanos M; Marañón R; Rivas-García A; Manrique-Rodríguez S; Mora-Capín A; Fernández-Llamazares CM.

Adecuacy of pediatric antimicrobial prescribing in the Emergency Department at discharge.

Anales De Pediatria. 2022; 96(3): 179-189 [doi:10.1016/j.anpede.2020.11.015]

Garcia-Alfonso, P; Saiz-Rodriguez, M; Mondejar, R; Salazar, J; Paez, D; Borobia, AM; Safont, MJ; Garcia-Garcia, I; Colomer, R; Garcia-Gonzalez, X; Herrero, MJ; Lopez-Fernandez, LA; Abad-Santos, F.

Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines

Clinical & Translational Oncology. 2022; 24(3): 483-494 Nº de citas: 49 [doi:10.1007/s12094-021-02708-4]

Villanueva-Bueno C; Montecatine-Alonso E; Jiménez-Parrilla F; Fernández-Llamazares CM; Manrique-Rodríguez S; Zamora-Flores E; Dolz E; Fernández-Polo A; Catillo-Salinas F; Comuñas J; Gallego-Fernández C; González-López M; Gómez-Trevecedo Calvo MT; Gázquez-Pérez R; Álvarez Del Vayo-Benito C; Gil-Navarro MV.

Antimicrobial defined daily dose in neonatal population.

Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2022; 40(2): 59-65 [doi:10.1016/j.eimce.2021.05.012]

Narrillos-Moraza, A; Gomez-Martinez-Sagrera, P; Amor-Garcia, MA; Escudero-Vilaplana, V; Collado-Borrell, R; Villanueva-Bueno, C; Gomez-Centurion, I; Herranz-Alonso, A; Sanjurjo-Saez, M.

Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale

JMIR mHealth and uHealth. 2022; 10(2): Nº de citas: 23 [doi:10.2196/32826]

Enriquez-Gomez, A; Ortega-Navarro, C; Fernandez-Cordon, C; Diez-Villanueva, P; Martinez-Selles, M; de Lorenzo-Pinto, A; de Miguel-Yanes, JM.

Comparison of a polypharmacy-based scale with Charlson comorbidity index to predict 6-month mortality in chronic complex patients after an ED visit

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2022; 88(4): 1795-1803 Nº de citas: 4 [doi:10.1111/bcp.15096]

Vicente-Valor, J; Garcia-Gonzalez, X; Ibanez-Garcia, S; Duran-Garcia, ME; de Lorenzo-Pinto, A; Rodriguez-Gonzalez, C; Mendez-Fernandez, I; Percovich-Hualpa, JC; Herranz-Alonso, A; Sanjurjo-Saez, M.

PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort

BIOMEDICINE & PHARMACOTHERAPY. 2022; 146: 112519-112519 Nº de citas: 24 [doi:10.1016/j.biopha.2021.112519]